Early Detection and Screening Working Group
Christina Clarke Dur, PhD
Vice President, Epidemiology
GRAIL
Co-Chairs
Bree Mitchell, PhD
Senior Director, Translational Medicine and Innovation
Natera
Current Projects
ED&S Clinical Validation (FDA pre-submission and manuscript in preparation)
Participating Organizations
AOA Dx, Association for Molecular Pathology (AMP), AstraZeneca, Bio-Rad, Bristol Myers Squibb (BMS), Delfi Diagnostics, Exact Sciences, Friends of Cancer Research, Grail, Guardant Health, International Society of Liquid Biopsy (ISLB), Loxo Oncology, Lungevity, Merck, Natera, NeoGenomics, NIH / NCI, Novartis, PreAnalytiX, Prevent Cancer Foundation, Roche, Tecan, Ultima Genomics
Past Deliverables
Meetings
This working group meets on zoom every other *** from *** PM EST.
Special workshops and sessions:
Not applicable at this time.